%PDF-1.4
%
1 0 obj
<>
endobj
89 0 obj
<>stream
Creo Normalizer JTP
2024-03-28T10:03:27-07:00
2006-06-13T17:00:20-04:00
2024-03-28T10:03:27-07:00
uuid:fb08d506-219e-480a-af90-d34c611d87c3
uuid:6d276a77-1dd2-11b2-0a00-9000d812c4ff
application/pdf
endstream
endobj
2 0 obj
<>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
47 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
98 0 obj
[104 0 R]
endobj
84 0 obj
<>
endobj
99 0 obj
<>stream
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
10 0 0 10 53.1648 720.8835 Tm
(L)Tj
7 0 0 7 59.2744 720.8835 Tm
(UCAS)Tj
10 0 0 10 86.0119 720.8835 Tm
[(R.)-806.8 (C)]TJ
7 0 0 7 109.9191 720.8835 Tm
(HADWICK)Tj
0.80679 Tc 10 0 0 10 143.7437 720.8835 Tm
(,G)Tj
0 Tc 7 0 0 7 161.5313 720.8835 Tm
(UIDO)Tj
10 0 0 10 187.0928 720.8835 Tm
[(F.)-806.8 (P)]TJ
7 0 0 7 208.7802 720.8835 Tm
(AULI)Tj
10 0 0 10 225.4964 720.8835 Tm
(,)Tj
7 0 0 7 236.0645 720.8835 Tm
(AND)Tj
10 0 0 10 53.1648 709.8835 Tm
(R)Tj
7 0 0 7 59.8344 709.8835 Tm
(ICHARD)Tj
10 0 0 10 89.8278 709.8835 Tm
(B.)Tj
7 0 0 7 102.1591 709.8835 Tm
(VAN)Tj
10 0 0 10 120.4834 709.8835 Tm
(B)Tj
7 0 0 7 127.1529 709.8835 Tm
(REEMEN)Tj
0.38161 Tc 9.5 0 0 9.5 164.8395 709.8835 Tm
(...............)Tj
/T1_1 1 Tf
0 Tc 9.6132 0 Td
(1152)Tj
/T1_0 1 Tf
10 0 0 10 35.1648 688.8154 Tm
[(Selective)-228.4 (Effects)-228.4 (of)-228.4 (Nitric)-228.4 (Oxide)-228.4 (on)-228.4 (the)-228.4 (Disposition)-228.4 (of)]TJ
1.8 -1.1 Td
[(Chlorzoxazone)-604 (and)-603.9 (Dextromethorphan)-603.9 (in)-603.9 (Iso-)]TJ
0 -1.1 TD
[(lated)-527.2 (Perfused)-527.2 (Rat)-527.3 (Livers.)-527.3 (R)]TJ
7 0 0 7 177.2894 666.8154 Tm
(AGINI)Tj
10 0 0 10 202.3865 666.8154 Tm
(V)Tj
7 0 0 7 209.606 666.8154 Tm
(UPPUGALLA)Tj
-22.3487 -1.5714 Td
(AND)Tj
10 0 0 10 71.489 655.8154 Tm
(R)Tj
7 0 0 7 78.1586 655.8154 Tm
(EZA)Tj
10 0 0 10 94.9287 655.8154 Tm
(M)Tj
7 0 0 7 103.8182 655.8154 Tm
(EHVAR)Tj
0.38161 Tc 9.5 0 0 9.5 134.8243 655.8154 Tm
(....................)Tj
/T1_1 1 Tf
0 Tc 12.7727 0 Td
(1160)Tj
/T1_0 1 Tf
10 0 0 10 35.1648 634.7472 Tm
[(Expression,)-762.5 (Purification,)-762.5 (and)-762.5 (Characterization)-762.5 (of)]TJ
1.8 -1.1 Td
[(Mouse)-529.8 (Cyp2d22.)-529.8 (A)]TJ
7 0 0 7 137.3669 623.7472 Tm
(I)Tj
10 0 0 10 139.6979 623.7472 Tm
(-M)Tj
7 0 0 7 151.9172 623.7472 Tm
(ING)Tj
10 0 0 10 169.6547 623.7472 Tm
(Y)Tj
7 0 0 7 176.8742 623.7472 Tm
[(U)-756.9 (AND)]TJ
10 0 0 10 207.6872 623.7472 Tm
(R)Tj
7 0 0 7 214.3568 623.7472 Tm
(OBERT)Tj
10 0 0 10 242.6015 623.7472 Tm
(L.)Tj
-18.9437 -1.1 Td
(H)Tj
7 0 0 7 60.3843 612.7472 Tm
(AINING)Tj
0.38161 Tc 9.5 0 0 9.5 92.8054 612.7472 Tm
(...........................)Tj
/T1_1 1 Tf
0 Tc 17.1957 0 Td
(1167)Tj
/T1_0 1 Tf
10 0 0 10 35.1648 591.679 Tm
[(Pharmacokinetics)-543.2 (of)-543.2 (Atorvastatin)-543.1 (and)-543.2 (Its)-543.2 (Hydroxy)]TJ
1.8 -1.1 Td
[(Metabolites)-353.1 (in)-353.1 (Rats)-353.1 (and)-353.1 (the)-353.1 (Effects)-353.1 (of)-353.1 (Concom-)]TJ
T*
[(itant)-649.7 (Rifampicin)-649.7 (Single)-649.7 (Doses:)-649.7 (Relevance)-649.7 (of)]TJ
T*
[(First-Pass)-250.3 (Effect)-250.3 (from)-250.2 (Hepatic)-250.3 (Uptake)-250.3 (Transport-)]TJ
T*
[(ers,)-727.5 (and)-727.5 (Intestinal)-727.5 (and)-727.5 (Hepatic)-727.5 (Metabolism.)]TJ
T*
(Y)Tj
7 0 0 7 60.3843 536.679 Tm
(VONNE)Tj
10 0 0 10 88.6107 536.679 Tm
[(Y.)-373.3 (L)]TJ
7 0 0 7 108.1727 536.679 Tm
(AU)Tj
0.37331 Tc 10 0 0 10 118.2809 536.679 Tm
(,H)Tj
0 Tc 7 0 0 7 131.7332 536.679 Tm
(IDEAKI)Tj
10 0 0 10 159.5676 536.679 Tm
(O)Tj
7 0 0 7 166.7872 536.679 Tm
(KOCHI)Tj
0.37331 Tc 10 0 0 10 188.9496 536.679 Tm
(,Y)Tj
0 Tc 7 0 0 7 202.4019 536.679 Tm
(ONG)Tj
10 0 0 10 221.2971 536.679 Tm
(H)Tj
7 0 0 7 228.5167 536.679 Tm
(UANG)Tj
10 0 0 10 248.733 536.679 Tm
(,)Tj
7 0 0 7 53.1648 525.679 Tm
(AND)Tj
10 0 0 10 71.489 525.679 Tm
(L)Tj
7 0 0 7 77.5986 525.679 Tm
(ESLIE)Tj
10 0 0 10 99.8149 525.679 Tm
[(Z.)-316.2 (B)]TJ
7 0 0 7 118.2559 525.679 Tm
(ENET)Tj
0.38161 Tc 9.5 0 0 9.5 140.8145 525.679 Tm
(...................)Tj
/T1_1 1 Tf
0 Tc 12.1421 0 Td
(1175)Tj
/T1_0 1 Tf
-0.01961 Tc 10 0 0 10 35.1648 504.6108 Tm
[(First-Pass)-216.2 (Effects)-216.2 (of)-216.2 (Verapamil)-216.2 (on)-216.2 (the)-216.2 (Intestinal)-216.2 (Absorp-)]TJ
1.8 -1.1 Td
[(tion)-364.5 (and)-364.5 (Liver)-364.5 (Disposition)-364.5 (of)-364.5 (Fexofenadine)-364.5 (in)-364.5 (the)]TJ
T*
[(Porcine)-698 (Model.)-698 (N)]TJ
-0.028 Tc 7 0 0 7 130.7566 482.6108 Tm
(ICLAS)Tj
0 Tc 10 0 0 10 156.98 482.6108 Tm
(P)Tj
-0.028 Tc 7 0 0 7 162.3436 482.6108 Tm
(ETRI)Tj
0.67841 Tc 10 0 0 10 177.1138 482.6108 Tm
(,E)Tj
-0.028 Tc 7 0 0 7 192.3113 482.6108 Tm
(BBA)Tj
0 Tc 10 0 0 10 213.0956 482.6108 Tm
(B)Tj
-0.028 Tc 7 0 0 7 219.5692 482.6108 Tm
(ERGMAN)Tj
0 Tc 10 0 0 10 248.7245 482.6108 Tm
(,)Tj
-19.556 -1.1 Td
(P)Tj
-0.028 Tc 7 0 0 7 58.5284 471.6108 Tm
(ATRIK)Tj
0 Tc 10 0 0 10 83.4763 471.6108 Tm
(F)Tj
-0.028 Tc 7 0 0 7 88.8399 471.6108 Tm
(ORSELL)Tj
0.4346 Tc 10 0 0 10 114.1103 471.6108 Tm
(,M)Tj
-0.028 Tc 7 0 0 7 129.6501 471.6108 Tm
(IKAEL)Tj
0 Tc 10 0 0 10 154.206 471.6108 Tm
(H)Tj
-0.028 Tc 7 0 0 7 161.2295 471.6108 Tm
(EDELAND)Tj
0.4346 Tc 10 0 0 10 192.9049 471.6108 Tm
(,U)Tj
-0.028 Tc 7 0 0 7 206.7749 471.6108 Tm
(LF)Tj
0 Tc 10 0 0 10 219.0946 471.6108 Tm
(B)Tj
-0.028 Tc 7 0 0 7 225.5682 471.6108 Tm
(ONDES)Tj
0 Tc 10 0 0 10 247.9195 471.6108 Tm
(-)Tj
-0.028 Tc 7 0 0 7 53.1648 460.6108 Tm
(SON)Tj
0.2966 Tc 10 0 0 10 66.5769 460.6108 Tm
(,L)Tj
-0.028 Tc 7 0 0 7 77.9563 460.6108 Tm
(ARS)Tj
0 Tc 10 0 0 10 94.1454 460.6108 Tm
(K)Tj
-0.028 Tc 7 0 0 7 101.1689 460.6108 Tm
(NUTSON)Tj
0 Tc 10 0 0 10 128.3783 460.6108 Tm
(,)Tj
-0.028 Tc 7 0 0 7 133.844 460.6108 Tm
(AND)Tj
0 Tc 10 0 0 10 151.5802 460.6108 Tm
(H)Tj
-0.028 Tc 7 0 0 7 158.6037 460.6108 Tm
(ANS)Tj
0 Tc 10 0 0 10 175.1778 460.6108 Tm
(L)Tj
-0.028 Tc 7 0 0 7 181.0914 460.6108 Tm
(ENNERNA)Tj
0.1664 Tc 4.0819 0 Td
(\250S)Tj
0.38161 Tc 9.5 0 0 9.5 224.8649 460.6108 Tm
(.....)Tj
/T1_1 1 Tf
0 Tc 3.2947 0 Td
(1182)Tj
/T1_0 1 Tf
10 0 0 10 35.1648 439.5426 Tm
[(Induction)-308.8 (of)-308.8 (Genes)-308.8 (for)-308.8 (Metabolism)-308.8 (and)-308.8 (Transport)-308.8 (by)]TJ
/T1_2 1 Tf
1.8 -1.1 Td
(trans)Tj
/T1_0 1 Tf
[0.1 (-Stilbene)-782.9 (Oxide)-782.9 (in)-782.9 (Livers)-782.9 (of)-782.9 (Sprague-)]TJ
T*
[(Dawley)-370.4 (and)-370.4 (Wistar-Kyoto)-370.4 (Rats.)-370.4 (A.)-370.4 (L.)-370.4 (S)]TJ
7 0 0 7 220.0832 417.5426 Tm
(LITT)Tj
0.37041 Tc 10 0 0 10 235.2455 417.5426 Tm
[(,N)370.4 (.)]TJ
0 Tc -18.2081 -1.1 Td
[(J.)-437.5 (C)]TJ
7 0 0 7 70.599 406.5426 Tm
(HERRINGTON)Tj
0.4375 Tc 10 0 0 10 116.0928 406.5426 Tm
[(,C)437.5 (.D)437.5 (.F)]TJ
0 Tc 7 0 0 7 156.1661 406.5426 Tm
(ISHER)Tj
0.4375 Tc 10 0 0 10 176.3895 406.5426 Tm
[(,M)437.6 (.N)]TJ
0 Tc 7 0 0 7 206.2482 406.5426 Tm
(EGISHI)Tj
10 0 0 10 229.1876 406.5426 Tm
(,)Tj
7 0 0 7 236.0624 406.5426 Tm
(AND)Tj
10 0 0 10 53.1648 395.5426 Tm
[(C.)-316.2 (D.)-316.2 (K)]TJ
7 0 0 7 85.597 395.5426 Tm
(LAASSEN)Tj
0.38161 Tc 9.5 0 0 9.5 122.8107 395.5426 Tm
(......................)Tj
/T1_1 1 Tf
0 Tc 14.0373 0 Td
(1190)Tj
/T1_0 1 Tf
10 0 0 10 35.1648 374.4631 Tm
[(Factors)-540.3 (Influencing)-540.3 (Midazolam)-540.3 (Hydroxylation)-540.3 (Ac-)]TJ
1.8 -1.1 Td
[(tivity)-568.2 (in)-568.2 (Human)-568.2 (Liver)-568.2 (Microsomes.)-568.2 (P)]TJ
7 0 0 7 219.0655 363.4631 Tm
(ING)Tj
10 0 0 10 237.1865 363.4631 Tm
(H)Tj
7 0 0 7 244.4061 363.4631 Tm
(E)Tj
10 0 0 10 248.6832 363.4631 Tm
(,)Tj
-19.5518 -1.1 Td
(M)Tj
7 0 0 7 62.0542 352.4631 Tm
(ICHAEL)Tj
10 0 0 10 92.5093 352.4631 Tm
[(H.)-479.2 (C)]TJ
7 0 0 7 113.6909 352.4631 Tm
(OURT)Tj
0.4792 Tc 10 0 0 10 132.7453 352.4631 Tm
(,D)Tj
0 Tc 7 0 0 7 147.2573 352.4631 Tm
(AVID)Tj
10 0 0 10 169.5432 352.4631 Tm
[(J.)-479.2 (G)]TJ
7 0 0 7 187.945 352.4631 Tm
(REENBLATT)Tj
10 0 0 10 228.7767 352.4631 Tm
(,)Tj
7 0 0 7 236.0692 352.4631 Tm
(AND)Tj
10 0 0 10 53.1648 341.4631 Tm
(L)Tj
7 0 0 7 59.2744 341.4631 Tm
(ISA)Tj
10 0 0 10 73.7135 341.4631 Tm
(L.)Tj
7 0 0 7 85.485 341.4631 Tm
(VON)Tj
10 0 0 10 103.8091 341.4631 Tm
(M)Tj
7 0 0 7 112.6986 341.4631 Tm
(OLTKE)Tj
0.38161 Tc 9.5 0 0 9.5 140.817 341.4631 Tm
(...................)Tj
/T1_1 1 Tf
0 Tc 12.1419 0 Td
(1198)Tj
/T1_0 1 Tf
10 0 0 10 35.1648 320.3835 Tm
[(Stochastic)-331.5 (Prediction)-331.5 (of)-331.5 (CYP3A-Mediated)-331.5 (Inhibition)]TJ
1.8 -1.1 Td
[(of)-267 (Midazolam)-267 (Clearance)-267 (by)-267 (Ketoconazole.)-267 (J)]TJ
7 0 0 7 231.737 309.3835 Tm
(ENNY)Tj
10 0 0 10 53.1648 298.3835 Tm
[(Y.)-242.9 (C)]TJ
7 0 0 7 71.9828 298.3835 Tm
(HIEN)Tj
0.2429 Tc 10 0 0 10 88.699 298.3835 Tm
(,A)Tj
0 Tc 7 0 0 7 100.8474 298.3835 Tm
(ROONRUT)Tj
10 0 0 10 137.108 298.3835 Tm
(L)Tj
7 0 0 7 143.2176 298.3835 Tm
(UCKSIRI)Tj
0.2429 Tc 10 0 0 10 171.2181 298.3835 Tm
(,C)Tj
0 Tc 7 0 0 7 182.8165 298.3835 Tm
(HARLES)Tj
10 0 0 10 212.469 298.3835 Tm
[(S.)-242.9 (E)]TJ
7 0 0 7 229.0671 298.3835 Tm
(RNEST)Tj
10 0 0 10 53.1648 287.3835 Tm
[(II,)-338.6 (J.)-338.6 (C)]TJ
7 0 0 7 82.1561 287.3835 Tm
(HRISTOPHER)Tj
10 0 0 10 128.7122 287.3835 Tm
(G)Tj
7 0 0 7 135.9318 287.3835 Tm
(ORSKI)Tj
0.33859 Tc 10 0 0 10 156.9322 287.3835 Tm
(,S)Tj
0 Tc 7 0 0 7 168.3781 287.3835 Tm
(TEVEN)Tj
10 0 0 10 194.7038 287.3835 Tm
[(A.)-338.6 (W)]TJ
7 0 0 7 217.249 287.3835 Tm
(RIGHTON)Tj
10 0 0 10 248.7426 287.3835 Tm
(,)Tj
7 0 0 7 336.1648 720.8835 Tm
(AND)Tj
10 0 0 10 354.489 720.8835 Tm
(S)Tj
7 0 0 7 360.0486 720.8835 Tm
(TEPHEN)Tj
10 0 0 10 390.042 720.8835 Tm
[(D.)-316.2 (H)]TJ
7 0 0 7 410.1429 720.8835 Tm
(ALL)Tj
0.38161 Tc 9.5 0 0 9.5 429.8222 720.8835 Tm
(..................)Tj
/T1_1 1 Tf
0 Tc 11.5098 0 Td
(1208)Tj
/T1_0 1 Tf
10 0 0 10 318.1648 699.9631 Tm
[(The)-230.4 (Novel)-230.4 (UGT1A9)-230.4 (Intronic)-230.4 (I399)-230.4 (Polymorphism)-230.4 (Ap-)]TJ
1.8 -1.1 Td
[(pears)-239.2 (as)-239.2 (a)-239.2 (Predictor)-239.2 (of)-239.2 (7-Ethyl-10-Hydroxycamp-)]TJ
T*
[(tothecin)-588.3 (Glucuronidation)-588.3 (Levels)-588.3 (in)-588.3 (the)-588.3 (Liver.)]TJ
T*
(H)Tj
7 0 0 7 343.3843 666.9631 Tm
(UGO)Tj
10 0 0 10 364.7114 666.9631 Tm
(G)Tj
7 0 0 7 371.9309 666.9631 Tm
(IRARD)Tj
0.6165 Tc 10 0 0 10 393.7083 666.9631 Tm
(,L)Tj
0 Tc 7 0 0 7 408.4825 666.9631 Tm
(YNE)Tj
10 0 0 10 429.0326 666.9631 Tm
(V)Tj
7 0 0 7 436.2521 666.9631 Tm
(ILLENEUVE)Tj
0.6165 Tc 10 0 0 10 475.1308 666.9631 Tm
(,M)Tj
0 Tc 7 0 0 7 492.6849 666.9631 Tm
(ICHAEL)Tj
10 0 0 10 524.5121 666.9631 Tm
(H.)Tj
-18.8347 -1.1 Td
(C)Tj
7 0 0 7 342.8344 655.9631 Tm
(OURT)Tj
0.4062 Tc 10 0 0 10 361.8887 655.9631 Tm
(,L)Tj
0 Tc 7 0 0 7 374.5607 655.9631 Tm
(OUIS)Tj
10 0 0 10 390.892 655.9631 Tm
(-C)Tj
7 0 0 7 400.8914 655.9631 Tm
(HARLES)Tj
10 0 0 10 432.1773 655.9631 Tm
(F)Tj
7 0 0 7 437.737 655.9631 Tm
(ORTIER)Tj
0.4062 Tc 10 0 0 10 463.0144 655.9631 Tm
(,P)Tj
0 Tc 7 0 0 7 475.1364 655.9631 Tm
(ATRICK)Tj
10 0 0 10 505.2534 655.9631 Tm
(C)Tj
7 0 0 7 511.923 655.9631 Tm
(ARON)Tj
10 0 0 10 531.7543 655.9631 Tm
(,)Tj
-19.559 -1.1 Td
(Q)Tj
7 0 0 7 343.3843 644.9631 Tm
(IN)Tj
10 0 0 10 354.295 644.9631 Tm
(H)Tj
7 0 0 7 361.5146 644.9631 Tm
(AO)Tj
0.35249 Tc 10 0 0 10 371.6228 644.9631 Tm
(,L)Tj
0 Tc 7 0 0 7 383.7578 644.9631 Tm
(ISA)Tj
10 0 0 10 398.5606 644.9631 Tm
(L.)Tj
7 0 0 7 410.6956 644.9631 Tm
(VON)Tj
10 0 0 10 429.3835 644.9631 Tm
(M)Tj
7 0 0 7 438.2729 644.9631 Tm
(OLTKE)Tj
0.35249 Tc 10 0 0 10 461.2123 644.9631 Tm
(,D)Tj
0 Tc 7 0 0 7 474.4573 644.9631 Tm
(AVID)Tj
10 0 0 10 495.4762 644.9631 Tm
[(J.)-352.5 (G)]TJ
7 0 0 7 512.6109 644.9631 Tm
(REEN)Tj
10 0 0 10 530.8882 644.9631 Tm
(-)Tj
7 0 0 7 336.1648 633.9631 Tm
(BLATT)Tj
10 0 0 10 358.7191 633.9631 Tm
(,)Tj
7 0 0 7 364.3809 633.9631 Tm
(AND)Tj
10 0 0 10 382.7051 633.9631 Tm
(C)Tj
7 0 0 7 389.3747 633.9631 Tm
(HANTAL)Tj
10 0 0 10 421.3072 633.9631 Tm
(G)Tj
7 0 0 7 428.5267 633.9631 Tm
(UILLEMETTE)Tj
0.38161 Tc 9.5 0 0 9.5 477.8472 633.9631 Tm
(..........)Tj
/T1_1 1 Tf
0 Tc 6.4545 0 Td
(1220)Tj
/T1_0 1 Tf
10 0 0 10 318.1648 613.0426 Tm
[(Drug-Drug)-846 (Interaction)-846 (between)-846 (Pitavastatin)-846 (and)]TJ
1.8 -1.1 Td
[(Various)-399.1 (Drugs)-399.1 (via)-399.1 (OATP1B1.)-399.1 (M)]TJ
7 0 0 7 474.6132 602.0426 Tm
(ASARU)Tj
10 0 0 10 502.3281 602.0426 Tm
(H)Tj
7 0 0 7 509.5477 602.0426 Tm
(IRANO)Tj
10 0 0 10 531.7101 602.0426 Tm
(,)Tj
-19.5545 -1.1 Td
(K)Tj
7 0 0 7 343.3843 591.0426 Tm
(AZUYA)Tj
10 0 0 10 371.7471 591.0426 Tm
(M)Tj
7 0 0 7 380.6365 591.0426 Tm
(AEDA)Tj
0.3869 Tc 10 0 0 10 400.0759 591.0426 Tm
(,Y)Tj
0 Tc 7 0 0 7 413.6646 591.0426 Tm
(OSHIHISA)Tj
10 0 0 10 450.1965 591.0426 Tm
(S)Tj
7 0 0 7 455.7561 591.0426 Tm
(HITARA)Tj
10 0 0 10 482.1956 591.0426 Tm
(,)Tj
7 0 0 7 488.5648 591.0426 Tm
(AND)Tj
10 0 0 10 507.5963 591.0426 Tm
(Y)Tj
7 0 0 7 514.8159 591.0426 Tm
(UICHI)Tj
10 0 0 10 336.1648 580.0426 Tm
(S)Tj
7 0 0 7 341.7244 580.0426 Tm
(UGIYAMA)Tj
0.38161 Tc 9.5 0 0 9.5 381.8132 580.0426 Tm
(..........................)Tj
/T1_1 1 Tf
0 Tc 16.5633 0 Td
(1229)Tj
/T1_3 1 Tf
8 0 0 8 305.1648 559.1222 Tm
(\001)Tj
/T1_0 1 Tf
6 0 0 6 307.3266 559.1222 Tm
(S)Tj
10 0 0 10 318.1656 559.1222 Tm
(Glutathione)Tj
/T1_2 1 Tf
5.2487 0 Td
(S)Tj
/T1_0 1 Tf
[(-Transferase)-527 (Omega)-527 (1)-527 (and)-527 (Omega)-527 (2)]TJ
-3.4488 -1.1 Td
[(Pharmacogenomics.)-369.3 (B)]TJ
7 0 0 7 427.3426 548.1222 Tm
(AIDEHI)Tj
10 0 0 10 455.1372 548.1222 Tm
(M)Tj
7 0 0 7 464.0267 548.1222 Tm
(UKHERJEE)Tj
0.36929 Tc 10 0 0 10 499.4123 548.1222 Tm
(,O)Tj
0 Tc 7 0 0 7 512.8249 548.1222 Tm
(RESTE)Tj
10 0 0 10 336.1648 537.1222 Tm
[(E.)-228.7 (S)]TJ
7 0 0 7 352.6208 537.1222 Tm
(ALAVAGGIONE)Tj
0.2287 Tc 10 0 0 10 403.9387 537.1222 Tm
(,L)Tj
0 Tc 7 0 0 7 414.8351 537.1222 Tm
(INDA)Tj
10 0 0 10 434.6154 537.1222 Tm
[(L.)-228.7 (P)]TJ
7 0 0 7 451.0715 537.1222 Tm
(ELLEYMOUNTER)Tj
0.2287 Tc 10 0 0 10 507.8424 537.1222 Tm
(,I)Tj
0 Tc 7 0 0 7 515.959 537.1222 Tm
(RENE)Tj
10 0 0 10 336.1648 526.1222 Tm
(M)Tj
7 0 0 7 345.0542 526.1222 Tm
(OON)Tj
0.2312 Tc 10 0 0 10 360.2165 526.1222 Tm
(,B)Tj
0 Tc 7 0 0 7 371.6984 526.1222 Tm
(RUCE)Tj
-0.00011 Tc 10 0 0 10 392.6802 526.1222 Tm
[(W.)-231.3 (E)]TJ
0 Tc 7 0 0 7 413.0417 526.1222 Tm
(CKLOFF)Tj
0.2312 Tc 10 0 0 10 439.8801 526.1222 Tm
(,D)Tj
0 Tc 7 0 0 7 451.912 526.1222 Tm
(ANIEL)Tj
10 0 0 10 475.2179 526.1222 Tm
[(J.)-231.2 (S)]TJ
7 0 0 7 489.4797 526.1222 Tm
(CHAID)Tj
0.2312 Tc 10 0 0 10 511.642 526.1222 Tm
(,E)Tj
0 Tc 7 0 0 7 522.564 526.1222 Tm
(RIC)Tj
10 0 0 10 336.1648 515.1222 Tm
[(D.)-316.2 (W)]TJ
7 0 0 7 358.4855 515.1222 Tm
(IEBEN)Tj
10 0 0 10 379.0939 515.1222 Tm
(,)Tj
7 0 0 7 384.7557 515.1222 Tm
(AND)Tj
10 0 0 10 403.0799 515.1222 Tm
(R)Tj
7 0 0 7 409.7495 515.1222 Tm
(ICHARD)Tj
-0.00011 Tc 10 0 0 10 439.7429 515.1222 Tm
[(M.)-316.3 (W)]TJ
0 Tc 7 0 0 7 463.7335 515.1222 Tm
(EINSHILBOUM)Tj
0.38161 Tc 9.5 0 0 9.5 519.8623 515.1222 Tm
(...)Tj
/T1_1 1 Tf
0 Tc 2.0318 0 Td
(1237)Tj
/T1_0 1 Tf
10 0 0 10 318.1648 494.2017 Tm
[(Involvement)-443.5 (of)-443.4 (Transporters)-443.4 (in)-443.4 (the)-443.4 (Hepatic)-443.4 (Uptake)]TJ
1.8 -1.1 Td
[(and)-444.3 (Biliary)-444.3 (Excretion)-444.3 (of)-444.3 (Valsartan,)-444.3 (a)-444.3 (Selective)]TJ
T*
[(Antagonist)-355.4 (of)-355.4 (the)-355.4 (Angiotensin)-355.4 (II)-355.4 (AT1-Receptor,)]TJ
T*
[(in)-1034.1 (Humans.)-1034.1 (W)]TJ
7 0 0 7 409.8933 461.2017 Tm
(AKABA)Tj
10 0 0 10 445.1197 461.2017 Tm
(Y)Tj
7 0 0 7 452.3392 461.2017 Tm
(AMASHIRO)Tj
1.0341 Tc 10 0 0 10 489.6709 461.2017 Tm
(,K)Tj
0 Tc 7 0 0 7 509.7312 461.2017 Tm
(AZUYA)Tj
10 0 0 10 336.1648 450.2017 Tm
(M)Tj
7 0 0 7 345.0542 450.2017 Tm
(AEDA)Tj
0.4153 Tc 10 0 0 10 364.4936 450.2017 Tm
(,M)Tj
0 Tc 7 0 0 7 380.0363 450.2017 Tm
(ASAKAZU)Tj
10 0 0 10 417.6293 450.2017 Tm
(H)Tj
7 0 0 7 424.8488 450.2017 Tm
(IROUCHI)Tj
0.4153 Tc 10 0 0 10 454.0114 450.2017 Tm
(,Y)Tj
0 Tc 7 0 0 7 467.8842 450.2017 Tm
(ASUHISA)Tj
10 0 0 10 502.3691 450.2017 Tm
(A)Tj
7 0 0 7 509.5886 450.2017 Tm
(DACHI)Tj
10 0 0 10 531.751 450.2017 Tm
(,)Tj
-19.5586 -1.1 Td
(Z)Tj
7 0 0 7 342.2744 439.2017 Tm
(HUOHAN)Tj
10 0 0 10 375.7609 439.2017 Tm
(H)Tj
7 0 0 7 382.9804 439.2017 Tm
(U)Tj
0.31619 Tc 10 0 0 10 388.0345 439.2017 Tm
(,,)Tj
0 Tc 7 0 0 7 399.3581 439.2017 Tm
(AND)Tj
10 0 0 10 417.6823 439.2017 Tm
(Y)Tj
7 0 0 7 424.9018 439.2017 Tm
(UICHI)Tj
10 0 0 10 447.5031 439.2017 Tm
(S)Tj
7 0 0 7 453.0627 439.2017 Tm
(UGIYAMA)Tj
0.38161 Tc 9.5 0 0 9.5 495.8561 439.2017 Tm
(.......)Tj
/T1_1 1 Tf
0 Tc 4.5588 0 Td
(1247)Tj
/T1_0 1 Tf
10 0 0 10 318.1648 418.2926 Tm
[(Extrapolation)-623.6 (of)-623.6 (Preclinical)-623.6 (Pharmacokinetics)-623.6 (and)]TJ
1.8 -1.1 Td
[(Molecular)-299.1 (Feature)-299.1 (Analysis)-299.1 (of)-299.1 (\223Discovery-Like\224)]TJ
T*
[(Molecules)-430.4 (to)-430.4 (Predict)-430.4 (Human)-430.4 (Pharmacokinetics.)]TJ
T*
(C)Tj
7 0 0 7 342.8344 385.2926 Tm
(HRISTOPHER)Tj
10 0 0 10 393.7427 385.2926 Tm
[(A.)-773.8 (E)]TJ
7 0 0 7 417.3104 385.2926 Tm
(VANS)Tj
0.7738 Tc 10 0 0 10 436.3647 385.2926 Tm
(,L)Tj
0 Tc 7 0 0 7 452.7129 385.2926 Tm
(ARRY)Tj
10 0 0 10 479.8978 385.2926 Tm
[(J.)-773.8 (J)]TJ
7 0 0 7 497.9158 385.2926 Tm
(OLIVETTE)Tj
10 0 0 10 531.7405 385.2926 Tm
(,)Tj
-19.5576 -1.1 Td
(R)Tj
7 0 0 7 342.8344 374.2926 Tm
(AKESH)Tj
10 0 0 10 369.3277 374.2926 Tm
(N)Tj
7 0 0 7 376.5472 374.2926 Tm
(AGILLA)Tj
10 0 0 10 402.5947 374.2926 Tm
(,)Tj
7 0 0 7 408.2565 374.2926 Tm
(AND)Tj
10 0 0 10 426.5807 374.2926 Tm
(K)Tj
7 0 0 7 433.8002 374.2926 Tm
(EITH)Tj
-0.00011 Tc 10 0 0 10 452.9015 374.2926 Tm
[(W.)-316.3 (W)]TJ
0 Tc 7 0 0 7 477.4421 374.2926 Tm
(ARD)Tj
0.38161 Tc 9.5 0 0 9.5 495.8444 374.2926 Tm
(.......)Tj
/T1_1 1 Tf
0 Tc 4.56 0 Td
(1255)Tj
/T1_3 1 Tf
8 0 0 8 305.1648 353.3835 Tm
(\001)Tj
/T1_0 1 Tf
6 0 0 6 307.3266 353.3835 Tm
(S)Tj
10 0 0 10 318.1656 353.3835 Tm
[(Profiling)-304.8 (the)-304.8 (Hepatic)-304.8 (Effects)-304.8 (of)-304.8 (Flutamide)-304.8 (in)-304.8 (Rats:)-304.8 (A)]TJ
1.7999 -1.1 Td
[(Microarray)-798.5 (Comparison)-798.5 (with)-798.6 (Classical)-798.6 (Aryl)]TJ
T*
[(Hydrocarbon)-701.1 (Receptor)-701.1 (Ligands)-701.1 (and)-701.1 (Atypical)]TJ
T*
[(CYP1A)-349.4 (Inducers.)-349.4 (K)]TJ
7 0 0 7 418.9688 320.3835 Tm
(EVIN)Tj
10 0 0 10 439.1794 320.3835 Tm
[(J.)-349.4 (C)]TJ
7 0 0 7 455.7329 320.3835 Tm
(OE)Tj
0.3494 Tc 10 0 0 10 465.0641 320.3835 Tm
(,S)Tj
0 Tc 7 0 0 7 476.6179 320.3835 Tm
(IDNEY)Tj
10 0 0 10 501.8826 320.3835 Tm
[(D.)-349.4 (N)]TJ
7 0 0 7 522.3159 320.3835 Tm
(EL)Tj
10 0 0 10 530.87 320.3835 Tm
(-)Tj
7 0 0 7 336.1648 309.3835 Tm
(SON)Tj
0.27609 Tc 10 0 0 10 350.165 309.3835 Tm
(,R)Tj
0 Tc 7 0 0 7 362.0958 309.3835 Tm
(OGER)Tj
10 0 0 10 383.9115 309.3835 Tm
[(G.)-276.1 (U)]TJ
7 0 0 7 403.6118 309.3835 Tm
(LRICH)Tj
0.27609 Tc 10 0 0 10 424.6122 309.3835 Tm
(,Y)Tj
0 Tc 7 0 0 7 437.093 309.3835 Tm
(UDONG)Tj
10 0 0 10 465.1248 309.3835 Tm
(H)Tj
7 0 0 7 472.3444 309.3835 Tm
(E)Tj
0.27609 Tc 10 0 0 10 476.6214 309.3835 Tm
(,X)Tj
0 Tc 7 0 0 7 489.1022 309.3835 Tm
(UDONG)Tj
10 0 0 10 517.134 309.3835 Tm
(D)Tj
7 0 0 7 524.3535 309.3835 Tm
(AI)Tj
10 0 0 10 531.7386 309.3835 Tm
(,)Tj
-19.5574 -1.1 Td
(O)Tj
7 0 0 7 343.3843 298.3835 Tm
(LIVIA)Tj
10 0 0 10 368.7498 298.3835 Tm
(C)Tj
7 0 0 7 375.4194 298.3835 Tm
(HENG)Tj
0.63181 Tc 10 0 0 10 394.8588 298.3835 Tm
(,M)Tj
0 Tc 7 0 0 7 412.5663 298.3835 Tm
(ICHELLE)Tj
10 0 0 10 448.0469 298.3835 Tm
(C)Tj
7 0 0 7 454.7166 298.3835 Tm
(AGUYONG)Tj
0.63181 Tc 10 0 0 10 490.0952 298.3835 Tm
(,C)Tj
0 Tc 7 0 0 7 505.5828 298.3835 Tm
(HRIS)Tj
10 0 0 10 527.8472 298.3835 Tm
(J.)Tj
-19.1682 -1.1 Td
(R)Tj
7 0 0 7 342.8344 287.3835 Tm
(OBERTS)Tj
10 0 0 10 369.6729 287.3835 Tm
(,)Tj
7 0 0 7 375.3346 287.3835 Tm
(AND)Tj
10 0 0 10 393.6588 287.3835 Tm
[(J.)-316.2 (G)]TJ
7 0 0 7 410.4299 287.3835 Tm
(REG)Tj
10 0 0 10 427.5921 287.3835 Tm
(S)Tj
7 0 0 7 433.1517 287.3835 Tm
(LATTER)Tj
0.38161 Tc 9.5 0 0 9.5 465.8469 287.3835 Tm
(............)Tj
/T1_1 1 Tf
0 Tc 7.7177 0 Td
(1266)Tj
/T1_3 1 Tf
11 0 0 11 35.1648 94.8835 Tm
(\001)Tj
/T1_0 1 Tf
9 0 0 9 38.1355 94.8835 Tm
(S)Tj
10 0 0 10 48.1393 94.8835 Tm
[(Supplemental)-332.9 (material)-332.9 (is)-332.9 (available)-332.9 (online)-332.9 (at)-332.9 (http://dmd.aspetjournals.org.)]TJ
0.2025 -3.7 Td
[(About)-316.5 (the)-316.4 (cover:)-500 (Human)-316.4 (GSTO1)-316.4 (\(A\))-316.5 (and)-316.4 (GSTO2)-316.4 (\(B\))-316.5 (polymorphisms.)-316.5 (See)-316.4 (the)-316.5 (article)-316.5 (by)-316.4 (Mukherjee)-316.5 (et)-316.5 (al.)-316.5 (on)-316.4 (page)-316.4 (1237)]TJ
0 -1.2 TD
[(of)-332.9 (this)-332.9 (issue.)]TJ
ET
1 0 0 1 -9 -9 cm
/CS0 CS 1 SCN
52 w
/GS1 gs
44.165 62.884 m
47.165 62.884 l
S
3 w
47.165 87.384 m
567.165 87.384 l
S
52 w
564.165 62.884 m
567.165 62.884 l
S
3 w
44.165 38.383 m
564.165 38.383 l
S
1 0 0 1 9 9 cm
BT
/GS2 gs
/T1_2 1 Tf
10 0 0 10 35.1648 742.3835 Tm
[(Contents)-332.9 (\(cont\222d.\))]TJ
ET
BT
0 g
/GS3 gs
/T1_4 1 Tf
0 -9 9 0 568 388.25554 Tm
( at ASPET Journals on March 28, 2024)Tj
/GS3 gs
-8.888 0 Td
(dmd.aspetjournals.org)Tj
/GS3 gs
-7.55399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
69 0 obj
<>
endobj
50 0 obj
<>
endobj
53 0 obj
<>
endobj
56 0 obj
<>
endobj
59 0 obj
<>
endobj
96 0 obj
<>
endobj
60 0 obj
<>
endobj
62 0 obj
<>
endobj
61 0 obj
<>stream
HTPj0+tLq=@Rȡ54QCv6ݥ
haFmwEMGq3@U`{t :G:<Ե_i8G^x}~,@~Ev4BqTߧDK?8!E(i dûdݹW8m5u+ ?y0Y=Fݝͪ|-YS-B6wW.+ Chb
endstream
endobj
63 0 obj
<>stream
Hbd`ad`ddTpr,K-*NK-/.,p
!C,X_?'~'=PpF!fFFvd##scʢdMCKǔTbϼĒ=ǜ bԢ2(N00030f0012h_wk2̿~>/uwf]` \h
endstream
endobj
57 0 obj
<>
endobj
58 0 obj
<>stream
H|TkTg!$
a.;ҥXr"Db$1$ H)]~ֵݮg]ۭ9]=߉_?v?88>cMLleB=wFp\'(9ۃ폖ܗBJ}L+t*l,4cE>pׅ5]#eQM:FWE<,*'G+
U:IHT2Jȕvdy]BJ&0_%SԅL\T%1 &0l'6X8DZ[a&!օa) *?şy,LT ų.rBW4U/?)S2{ִiFBT<7-~Q~S[g\"\lJEG